The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure

Area of Science:

• Cardiology
• Pharmacology
• Public Health

Background:

• Hypertension management is crucial for preventing cardiovascular events.
• The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) investigated major antihypertensive drug classes.
• Older adults represent a significant population at risk for cardiovascular disease.

Purpose of the Study:

• To compare the efficacy and safety of four antihypertensive agents in patients aged 55 years and older.
• To evaluate chlorthalidone, doxazosin, amlodipine, and lisinopril for cardiovascular outcomes.
• To identify the optimal initial therapy for hypertension in this demographic.

Main Methods:

• The ALLHAT study was a large-scale, randomized controlled trial.
• Participants received chlorthalidone, doxazosin, amlodipine, or lisinopril.
• Outcomes included stroke, heart attack, and heart failure.

Main Results:

• The doxazosin group was discontinued early due to increased congestive heart failure.
• Chlorthalidone demonstrated at least equivalent efficacy to amlodipine and lisinopril across measured outcomes.
• Chlorthalidone showed superior performance in preventing heart failure compared to other agents.

Conclusions:

• Chlorthalidone is a safe and effective first-line antihypertensive treatment for older adults.
• Chlorthalidone offers a significant benefit in reducing heart failure incidence.
• The findings support chlorthalidone as a preferred agent in hypertension management for this population.